Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Merck”
Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Healthy
Germany
Sponsor: Roswell Park Cancer Institute
Healthy
United States
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Locally Advanced Head and Neck Squamous Cell Carcinoma
Belgium, France, Germany, Ireland, Italy +5 more
Sponsor: Merck Sharp & Dohme LLC
Moderate Renal Impairment
United States
Sponsor: Merck Sharp & Dohme LLC
Healthy
United States
Sponsor: NovoCure GmbH
Glioblastoma
United States, Canada, Czechia, France, Germany +7 more
Sponsor: Merck Sharp & Dohme LLC
Ovarian Cancer · Fallopian Tube Cancer · Peritoneal Neoplasms
United States, Australia, Belgium, Brazil, Canada +17 more
- A Trial to Evaluate the Effect of CD388/MK1406 on the Immunogenicity of Fluzone® HD Vaccine (CD388.SQ.1.08/MK-1406-007)Active Not Recruiting
Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Healthy Participants
United States
- Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living With HIVActive Not Recruiting
Sponsor: Dr. Karen Yeates
Cervical Cancer
Tanzania
Sponsor: Eikon Therapeutics
Non Small Cell Lung Cancer (Squamous or Non Squamous) · Stage 4 NSCLC
United States, Australia, Spain
Sponsor: Vir Biotechnology, Inc.
Locally Advanced or Metastatic HER2-Expressing Cancers
United States, Australia, France, Portugal, Spain
- Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic AlterationsActive Not Recruiting
Sponsor: Daiichi Sankyo
Metastatic Non Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +23 more
Sponsor: Merck Sharp & Dohme LLC
Pulmonary Arterial Hypertension
Japan
Sponsor: Merck Sharp & Dohme LLC
Esophageal Squamous Cell Carcinoma
United States, Brazil, Chile, China, Czechia +10 more
- Data-Driven Strategies for Patient Engagement About Cancer Clinical TrialsActive Not Recruiting
Sponsor: University of Southern California
Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm
United States
- Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate CancerActive Not Recruiting
Sponsor: AstraZeneca
Metastatic Castration-resistant Prostate Cancer
United States, Australia, Belgium, Brazil, Canada +12 more
Sponsor: Merck Sharp & Dohme LLC
Solid Tumors · Hematologic Malignancies
United States, Argentina, Australia, Austria, Belgium +46 more
Sponsor: Merck Sharp & Dohme LLC
Melanoma
United States, Argentina, Australia, Austria, Belgium +21 more
Sponsor: Latin American Cooperative Oncology Group
Lung Cancer · Non Small Cell Lung Cancer · Brain Metastases
Brazil
Sponsor: Merck Sharp & Dohme LLC
Healthy
Indonesia, Malaysia, Philippines, Puerto Rico, Singapore +2 more
- A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)Active Not Recruiting
Sponsor: AstraZeneca
Neurofibromatosis 1 · Neurofibroma Plexiform
China
- A Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Oesophageal Squamous Cell Carcinoma
United States, Brazil, China, Czechia, Japan +5 more
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer
United States, Chile, Greece, Hungary, Israel +6 more
- A Clinical Trial of MK-7262 and Enlicitide in Participants With High Lipoprotein(a) (MK-7262-004)Recruiting
Sponsor: Merck Sharp & Dohme LLC
Lipoprotein(a)
United States, Japan
Sponsor: EMD Serono Research & Development Institute, Inc.
Systematic Lupus Erythematosus · Cutaneous Lupus Erythematosus
United States, Canada, China, Germany, Switzerland